In the body Memantine reduces certain types of brain activity by binding to NMDA receptors and blocking the activity of glutamate. As a result, Memantine upregulates receptors in the brain and has a cognitive-enhancing effect.
Alpha-GPC was discovered in 1864 by a German chemist Adolph Strecker. Nowadays, it is routinely prescribed by doctors in Europe as a treatment for Alzheimer’s and other degenerative conditions. In body, Alpha-GPC is cleaved into glycerophosphate and free choline.